The EPS projection of HealthSouth Corporation (NYSE:HLS) for quarter ended 2016-09-30 is $0.61. Last week, the EPS forecast was $0.61 against target of $0.61, a month earlier. Two months ago, this estimate was $0.61 versus forecast of $0.61 three months earlier, implying a deviation of 0%.
HealthSouth Corporation (NYSE:HLS) stated that 18 days ago, its stock price was positively revised 1 times while negative revisions were 5.
In last week, the experts lowered EPS 0 times and increased EPS 0 times. In last 30, 120, 60 and 90 days, the experts upped revisions 0 , 3, 3, and 3, correspondingly.
EPS estimate downgrade for HealthSouth Corporation (NYSE:HLS) in the preceding 30, 120, 60 and 90 days were 0, 1, 0, and 0, correspondingly.
HealthSouth Corporation (NYSE:HLS) EPS target for the quarter closed 1 was $0.61, based on 7 recommendations. As reported on 2016-04-26 the EPS was $0.61. The change was $0.06, implying a percentage deviation of 10.91%. The projections showed a standard deviation of 0.02.
Quarterly Sales Estimates
HealthSouth Corporation (NYSE:HLS) yearly sales prediction for the fiscal 2017 stands at $989.812 and the median estimate is at $990. Almost 4 analysts issued sales target.
Highest sales target is $1001.55 while the lowest target is $977.7 showing standard deviation of 10.794%.
As many as 4 analysts have sales targets revised upside while 4 reduced sales estimates, implying a deviation of 0%.
Last month, 4 revised sales number projection on upside while 4 lowered the sales projections, implying a deviation of 0%.
A quarter ago, 4 hiked sales target and 4 reduced sales forecast. HealthSouth Corporation (NYSE:HLS) announced that the deviation in forecast was -0.538%.
1 Chart Pattern Every Investor Should Know
This little-known pattern preceded moves of 578% in ARWR, 562% in LCI, 513% in ICPT, 439% in EGRX, 408% in ADDUS and more...